Efficacy and Safety of the Low-molecular Heparin in Treatment and Prevention of the Acute Coronary Syndrome
Journal Title: Lviv Clinical Bulletin - Year 2013, Vol 1, Issue 1
Abstract
Introduction. For a long time, the main medication for treating and preventing of thrombotic complications was unfractionated heparin (UFH). However, despite its high efficiency, UFH has a number of disadvantages and side effects. Significant advantages over UFH are low molecular weight heparins or low molecular weight heparins (LMWH). LMWH is a product of enzymatic or chemical depolymerization of conventional heparin. The low molecular weight fractions of heparin obtained during the polymerization process have new pharmacodynamic properties. Today about 10 drugs of LMWH are used. They are obtained by various methods of depolymerization of UFH, resulting in fractions with a lower molecular weight (from 4000 to 6500 daltons). Aim. To review and analyze the current knowledge about the effectiveness and safety of use of LMWH for the treatment and prevention of acute coronary syndrome. Materials and methods. The content analysis, method of system and comparative analysis, the bibliosemantic method of study of actual scientific researches concerning the efficiency and safety of the use of LMWH for the treatment and prevention of acute coronary syndrome has been used. Comparison of the effectiveness of various preparations of low molecular weight heparins is carried out taking into account the results of multicenter studies. The results indicate that LMWH is an effective and safe remedy for the treatment of acute coronary syndrome and preventing coronary events in patients at different risk levels. LMWH are much less than UFH binding to plasma proteins that can neutralize their antithrombotic activity. The low affinity of LMWH to plasma proteins that neutralize heparin is due to their high bioavailability of low doses and greater predictability of anticoagulant response at high doses. LMWH have longer antithrombotic activity than UFH. While the half-life in blood plasma (T1 / 2) of UFH is, if judged by its activity against factor Xa, 50-60 minutes, T1 / 2 of LMWH after intravenous administration is within 1.5-4.5 hours. Significant duration of antithrombotic effect of LMWH allows them to be assigned once or twice a day. The bioavailability of most of the LMWH after deep subcutaneous injection is about 90.0%, whereas in case of UFH it is 15.0 – 20.0%. All of the considered features of pharmacokinetics and pharmacodynamics of LMFH suggest their undoubted advantage over UFH, which consists in the fact that with both – preventive and therapeutic purpose – subcutaneously constant dose can be administered. In addition, LMWH are resistant to inactivating of factor 4 of thrombocytes and do not increase their arrreation under the influence of various inductors. In the case of LMWH, the frequency of thrombocytopenia is much lower. Conclusions. LMWH is an effective and safe medication of the treatment of acute coronary syndrome and for the preventing of coronary events in patients at different risk levels.
Authors and Affiliations
I. Katerenchuk, O. Katerenchuk
Keywords
Related Articles
- EP ID EP255962
- DOI 10.25040/lkv2013.01.040
- Views 117
- Downloads 0
The Influence of Performance Therapy with Statins on Androgen Balance in Patients with Stable Angina in Combination with Type 2 Diabetes Mellitus
Introduction. Since cholesterol is a substrate for the synthesis of sex hormones, including testosterone, changes in androgen availability in patients taking statins can be expected. At the same time, the effect of stati...
Methodology of the Treatment of Pulmonary Tuberculosis
Introduction. Despite the significant successes of tuberculosis treatment, the epidemiological situation, which practically does not show a probable improvement ща the main epidemiological parameters, remains anxious. Ai...
Content of Some Endothelium-Dependent Vasoactive Substances of Blood Plasma, Indicators of Renin-Aldosterone System, Natriuretic Hormone in Patients with Decompensated Liver Cirrhosis and their Dependence on the Severity Grade of Portal Hypertension
Introduction. Liver cirrhosis is one of the most important and most difficult problems of modern hepatology. According to the statistics, each year liver cirrhosis kills nearly two million people. The question of the rel...
Iodine Deficiency Hypothyroidism in Residents of the Prykarpattia Region: Results of the First Phase of the Clinical Examination Using Pyruvate Dehydrogenase and α-ketonuria Tests
Introduction. According to a WHO study, about 30.0% of the Earth’s population is at an iodine deficiency (ID) risk; about 20 million people are mentally disturbed due to a deficit of iodine in the organism. The research...
Взаємов’язок рівня фракталкіну з немодифікованими і модифікованими чинниками серцево-судинного ризику, вираженістю атеросклерозного ураження вінцевих судин
Обстежено 131 хворого на ішемічну хворобу серця (ІХС). Залежно від наявності цукрового діабету (ЦД) 2-го типу хворих поділено на дві ґрупи: 1-ша ґрупа (n = 70) – хворі з супутнім ЦД 2-го типу, 2-га ґрупа (n = 61) – хворі...